• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Urology

UCLA Urology

UCLA Urology
  • About Us
    • Chair's Welcome
    • Awards and Recognition
    • Innovations and Technology
    • UCLA Institute of Urologic Oncology
    • Webinars
    • Contact Us
    • News and Events
    • Newsletters
    • Media Contact
    • Our History
    • Our Milestones
    • The Men's Clinic at UCLA
    • Jobs
    • Giving
  • Clinical Programs
    • Bladder Cancer
    • General Adult Urology
    • Kidney Cancer
    • Kidney Stone Center
    • Kidney Transplant Program
    • Male Urology
    • Minimally Invasive/Robotics Surgery
    • Pediatric Urology Program
    • Pelvic Medicine and Reconstruction
    • Prostate Cancer Program
    • Testicular Cancer
    • Urologic Oncology
  • Conditions Treated
    • Alphabetical List of Conditions
    • Adult Conditions
    • Cancer Conditions
    • Female Conditions
    • Male Conditions
    • Pediatric Conditions
  • For Patients
    • Appointment Request
    • myUCLAhealth
    • Clinical Updates
    • Community Impact
    • Contact Us
    • Preparing for Surgery
    • Healthy at Every Age
    • Interactive Procedure Videos
    • Maps and Directions
    • Patient Education
    • Patient Stories
    • Video Gallery
    • Webinars
    • Vital Signs Publications
    • UCLA Blood Donation
    • UCLA Overnight Accommodations
    • Urology Portal
  • Research
    • Bladder Cancer Research
    • Kidney Cancer Research
    • Male Urology Research
    • Pediatric Urology Research
    • Prostate Cancer Research
    • SPORE In Prostate Cancer
    • Health Services Research
    • Clinical Trials
  • Education
    • Residency
    • Fellowships
    • Medical Student Program
  • For Healthcare Professionals
    • How to Refer a Patient
    • Educational Opportunities
    • Physicians Updates & Clinical Updates
    • Publications by Urology Faculty
    • Events and CME Courses
    • eReferrals
  • Physician Directory
    • All Faculty (A-Z)
    • UCLA Faculty and Providers
    • UCLA Faculty - Affiliated Institutions
    • Joint Appointments/Research Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Urology

Research

Research

Research

  • Bladder Cancer Research
  • Kidney Cancer Research
  • Male Urology Research
  • Pediatric Urology Research
  • Prostate Cancer Research
  • SPORE In Prostate Cancer
    • Annual Symposium
    • Leadership (PDF)
    • Project & Cores
    • Investigators & Staff
    • Developmental Research Program
      • Awardees 2015-2016
      • Awardees 2014-2015
      • Awardees 2013-2014
    • Career Enhancement Program
      • Awardees 2015-2016
      • Awardees 2014-2015
      • Awardees 2013-2014
    • Clinical Trials
    • SPORE News
      • 2015-2016 News
      • 2013-2014 News
      • 2012 News
      • 2011 News
      • 2005-2010 News
    • Contact Information
    • Funding Opportunities
    • SPORE Calendar
    • Lecture Series
      • 2016-2017 Lecture Series
    • Resources
  • Health Services Research
    • IMPACT
    • Urologic Diseases in America
  • Clinical Trials
    • Find a Doctor
    • Frequently Asked Questions (FAQ)
    • Learn More About Clinical Trials
  • Bladder Cancer Research
  • Kidney Cancer Research
  • Male Urology Research
  • Pediatric Urology Research
  • Prostate Cancer Research
  • SPORE In Prostate Cancer
  • Health Services Research
  • Clinical Trials
  1. Home
  2. Research
  3. Bladder Cancer Research

Bladder Cancer Research

Share this

Research Bladder Cancer

The UCLA Department of Urology is committed to ongoing Bladder Cancer research in a quest to develop new treatments and cures for all urologic conditions, along with a commitment to educate and train the next generation of leading physicians and scientists.

Arie Belldegrun , MD

Arie Belldegrun , MD

Dr. Belldegrun is internationally recognized in the field of surgical and medical management of urological cancers, designing and conducting large-scale clinical trials, and in the development of innovative therapies for patients with localized and metastatic kidney, bladder, and prostate cancer. Dr. Belldegrun’s research laboratory at UCLA has been a pioneer in the fields of genetic cancer therapy, immunotherapy, cancer vaccines, and targeted molecular therapy for urological malignancies.

Dr. Arie Belldegrun's research focuses on targeted specific therapy and immunotherapy of kidney and prostate cancers. Belldegrun's laboratory reported on the cloning of a tissue specific and androgen responsive novel 620 bp PSA promoter sequence and upstream sequence. The enhanced gene expression of the resulting construct, combined with its tissue specificity and androgen responsiveness, provide the foundation for the development of tissue specific vectors for prostate cancer gene therapy.

Belldegrun's laboratory also has studied the feasibility of isolating functional dentrictic cells from the peripheral blood of renal cell carcinoma patients and has compared their transduction efficiency using various methods of transferring gene markers into dentritic cells.


Arnold Chin, MD, PhD

Arnold Chin, MD, PhD

Arnold Chin, M.D., Ph.D, is a physician-scientist dedicated to improving the lives of patients with urologic malignancies. Focused on bladder and prostate cancer, his research team studies how the immune system recognizes and modulates cancer growth, invasion, and metastases.

Current projects include understanding the mechanisms that distinct immune pathways use to regulate tumor growth and spread, which will be important in identifying targets for novel immune-based therapies. A second area is focused on understanding bladder cancer stem cells, which may be the origin of the cancer. These cells may be resistant to current therapies. Targeting the cancer stem cell population, the team is studying the molecular and genetic mechanisms and is developing a personalized therapy program for bladder cancer patients to match specific treatments with patients. Chin hopes his studies will determine which tumors may respond to specific treatments and design novel therapeutics that optimize the body’s own immune system to fight cancer.


Christopher Saigal, MD, PhD

Christopher Saigal, MD, PhD

Dr. Christopher Saigal’s research is focused on the nexus of quality of care and trends in medical technology.  The Urologic Diseases in America project, an ongoing, NIH-funded research enterprise, evaluates quality, cost, and technology trends in major urologic conditions such as prostate, kidney and bladder cancer, as well as benign diseases such as benign prostatic hyperplasia and kidney stones. Over 60 policy-relevant manuscripts have resulted from this project. Other major research efforts involve finding ways to use technology to improve decision making for patients in the setting of localized prostate cancer. Specifically, this research tests ways to improve “shared decision making” using computer applications. Dr. Saigal also leads the UCLA site for two national NCI-funded trials to examine outcomes of care in men treated for localized prostate cancer.

Dr. Saigal’s research is currently funded by the National Institutes of Health, National Cancer Institute and the Lance Armstrong Foundation.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest